Skip to main content
Clinical Trials/CTRI/2024/02/062831
CTRI/2024/02/062831Not yet recruitingPhase 4

A double blinded randomized controlled study to assess safety and effectiveness of carbetocin vs oxytocin during active management of third stage, for prevention of PPH in patients undergoing cesarean section - nil

siddaganga medical college and research institute0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • willing to participate
  • gestational age 36 weeks-41 weeks
  • patients undergoing cesarean section

Exclusion Criteria

  • hypertensive
  • pre eclampsia
  • ante partum hemorrhage
  • bleeding disorders
  • thrombocytopenia
  • blood coagulation abnormalities
  • cardiovascular disorders
  • renal disease
  • liver disease
  • general anesthesia
  • retained placenta
  • placenta accreta
  • placenta previa
  • previous pph
  • grand multipara
  • fibroid with pregnancy
  • prolonged labour
  • hypersensitivity to oxytocin or carbetocin
  • traumatic pph

Investigators

Sponsor
siddaganga medical college and research institute

Similar Trials